Abstract
Neuromyelitis optica spectrum disorders (NMOSD) involve neurodegenerative and demyelinating diseases that affect the central nervous system (CNS). An important molecule recognized as an NMOSD biomarker is the anti-aquaporin-4 (anti-AQP4) antibody, which is associated with the initial autoimmune response during NMOSD against the aquaporin-4 (AQP4) water channel in CNS typical cells. Howeve…